In vivo studies have shown a protective effect when mesenchymal stromal cells engineered to produce GLP-1 were transplanted directly into brain ventricles21 and the GLP-1 analog exenatide22 in an ALS mouse model, however there are still limited studies investigating this in ALS. The gene discussed is GCG; the disease is amyotrophic lateral sclerosis.